Application
From Living Cell Therapies to
Next-Generation Biologics
CellShot® enables non-destructive gene delivery across a broad spectrum of applications—from CRISPR-edited immune cells and RNA-based CAR therapies to advanced biologics manufacturing platforms.
Designed for living systems, CellShot bridges discovery, manufacturing, and clinical translation.
Cell & Gene Therapy Manufacturing
Building the Foundation for Next-Generation Cell & Gene Therapies
CellShot® ND-FFT technology is designed as a manufacturing-grade foundation for cell and gene therapies.
By integrating non-viral gene delivery, high cellular viability and expandability, and scalable manufacturing, CellShot enables cell engineering processes that remain robust throughout clinical manufacturing.
The 3 Pillars of the CGT Sector
Non-viral Gene Delivery
Core pillar of the platform, providing capabilities beyond viral vectors. It enables precise gene suppression or deletion and insertion into safe genomic loci.
High Viability & Expandability
Sets CellShot® apart from conventional methods. It minimizes damage while preserving proliferation capacity, supporting robust expansion.
Scalable Manufacturing
From R&D to large-scale GMP production, flow electroporation enables seamless adjustment of throughput without altering conditions.
CGT Modalities Enabled by CellShot®
From genome editing to repeatable cell programming
- CRISPR-edited T cells / NK cells
- mRNA CAR-T / CAR-NK
- Multi-gene / sequential editing
- Repeated transfection workflows
Our Solution
CellShot delivers safe, scalable, and damage-free nonviral gene transfer.
The 3 Applications of the CGT Sector
Asynchronized, Repeatable, Non-viral CRISPR EP
CRISPR KO/KI workflows optimized for cell fitness and scalable manufacturing.
- •Sequential KO/KI
- •Repeated EP without loss of viability
Multigenic mRNA EP with low-DMSO recovery
Transient RNA delivery enables fine-tuned immune modulation.
- •mRNA CAR expression
- •Transient RNA silencing
MSC / iPSC / Immune cell workflows
Scalable flow-based EP enables consistent cell processing.
- •Transient mRNA programming
- •Differentiation priming
The Future Applications of the Biologics Sector
Downstream cost & quality optimization
PFEP-assisted delivery improves AAV assembly efficiency.
- •Improved packaging efficiency
- •Reduced polishing burden
Safeguarding on-target activity
Concept-stage development of bispecific strategies.
- •Complementary to cell engineering
- •Enhancing safety profiles
Application Spectrum: From Cell Therapies to Next-Gen Biologics
CRISPR KO/KI
Precision genome editing
RNA-Multigenic Thearpy
Immune cell programming
MSC/iPSC RNA
Non-integrating modulation
AAV
Biologics manufacturing
Bi-Abs
Safety-oriented modulation